These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmaceutical sciences--1973: literature review of pharmaceutics. Herd AK; Haleblian JK J Pharm Sci; 1974 Jul; 63(7):995-1055. PubMed ID: 4604899 [No Abstract] [Full Text] [Related]
7. Pharmaceutical sciences--1972: literature review of pharmaceutics. I. Shah AC; Herd AK J Pharm Sci; 1973 Jul; 62(7):1033-65. PubMed ID: 4581952 [No Abstract] [Full Text] [Related]
8. Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects. Heimlich KR J Pharm Sci; 1972 Oct; 61(10):1686-9. PubMed ID: 5072432 [No Abstract] [Full Text] [Related]
9. Promises of Molecular Pharmaceutics in the Development of Novel Drug Delivery Formulations. Kumar P; Chaudhary B; Jain V; Baboota S; Shivanandy P; Alharbi KS; Ghoneim MM; Alshehri S; Imam SS; Gupta G; Gupta MM Curr Drug Deliv; 2023; 20(9):1262-1274. PubMed ID: 36380413 [TBL] [Abstract][Full Text] [Related]
10. [Systematic presentation of rational research on new drugs]. Ariëns EJ Farmaco Sci; 1968 Jan; 23(1):52-94. PubMed ID: 4892131 [No Abstract] [Full Text] [Related]
11. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771 [TBL] [Abstract][Full Text] [Related]
12. Theoretical comparison of release rates of drugs into sink and nonsink conditions. Guy RH; Hadgraft J J Pharm Sci; 1981 Nov; 70(11):1243-5. PubMed ID: 7299670 [No Abstract] [Full Text] [Related]
13. The solubility-permeability interplay and oral drug formulation design: Two heads are better than one. Dahan A; Beig A; Lindley D; Miller JM Adv Drug Deliv Rev; 2016 Jun; 101():99-107. PubMed ID: 27129443 [TBL] [Abstract][Full Text] [Related]
14. Paediatric oral biopharmaceutics: key considerations and current challenges. Batchelor HK; Fotaki N; Klein S Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013 [TBL] [Abstract][Full Text] [Related]
15. Absorption classification of oral drugs based on molecular surface properties. Bergström CA; Strafford M; Lazorova L; Avdeef A; Luthman K; Artursson P J Med Chem; 2003 Feb; 46(4):558-70. PubMed ID: 12570377 [TBL] [Abstract][Full Text] [Related]
16. [The role of biopharmaceutical parameters in drug development (author's transl)]. Thoma K Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191 [TBL] [Abstract][Full Text] [Related]
17. [Biologic availability and "1st pass" effect of drugs]. Rietbrock N; Keller F Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146 [TBL] [Abstract][Full Text] [Related]
18. [Importance of size of particles in practical pharmacy]. Renoz L J Pharm Belg; 1967; 22(1):41-56. PubMed ID: 4977286 [No Abstract] [Full Text] [Related]
19. A mathematical model of drug absorption. Goodacre BC; Murray PJ J Clin Hosp Pharm; 1981 Jun; 6(2):117-33. PubMed ID: 7343561 [TBL] [Abstract][Full Text] [Related]
20. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]